Growth Metrics

Galectin Therapeutics (GALT) Return on Capital Employed (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Galectin Therapeutics 165.77 Mn 151.67 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8,856.00
Dec 31, 2025 -26,973.00
Sep 30, 2025 192,312.00
Jun 30, 2025 -194,107.00
Mar 31, 2025 -30,671.00
Dec 31, 2024 164,342.00
Sep 30, 2024 -96,859.00
Jun 30, 2024 -6,697.00
Mar 31, 2024 14,117.00
Dec 31, 2023 -3,124.00
Sep 30, 2023 425.00
Jun 30, 2023 4,676.00
Mar 31, 2023 16,191.00
Dec 31, 2022 -29,675.00
Sep 30, 2022 -9,844.00
Jun 30, 2022 -6,710.00
Mar 31, 2022 -2,224.00
Dec 31, 2021 1,387.00
Sep 30, 2021 1,639.00
Jun 30, 2021 -666.00
Mar 31, 2021 -3,255.00
Dec 31, 2020 -2,962.00
Sep 30, 2020 -1,296.00
Jun 30, 2020 -1,356.00
Mar 31, 2020 -387.00
Dec 31, 2019 -654.00
Sep 30, 2019 1,580.00
Jun 30, 2019 11,901.00
Mar 31, 2019 1,960.00
Dec 31, 2018 -3,641.00
Sep 30, 2018 8,172.00
Jun 30, 2018 46,211.00
Mar 31, 2018 -6,342.00
Dec 31, 2017 -13,814.00
Sep 30, 2017 -25,431.00
Jun 30, 2017 -4,196.00
Mar 31, 2017 -975.00
Dec 31, 2016 -1,174.00
Sep 30, 2016 -2,888.00
Jun 30, 2016 -3,251.00
Mar 31, 2016 -1,446.00
Mar 31, 2015 -48.00
Dec 31, 2014 -767.00
Sep 30, 2014 -256.00
Jun 30, 2014 1,947.00
Mar 31, 2014 9,317.00
Dec 31, 2013 4,207.00
Sep 30, 2013 3,581.00
Jun 30, 2013 -7,247.00
Mar 31, 2013 -4,813.00
Dec 31, 2012 -1,259.00
Sep 30, 2012 -2,142.00
Jun 30, 2012 3,650.00
Mar 31, 2012 8,665.00
Dec 31, 2011 -8,861.00